Comparative clinical study to asses efficacy of bharangikanadi kashay and uroh pradeshi lavantakta taila snehana swedana in the management of tamaka shwasa w.r.t bronchial asthma

DrJayanti Dutta0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Duration not more than 2years
•2. History of intermittent or persistent asthma symptoms. FEV1 between 50% to 85% of predicted value.
•3. Non-smoker/left smoking past 3 months.
•4.Pre bronchodilator FEVI1 values in range of 60-80%
•5. Normal SGPT and serum creatinine

•2. Active upper respiratory tract infection within 3 weeks
•3. Acute sinus disease requiring antibiotic treatment within 1 week therapy, inhaled
•4. Medications: Warfarin, anti-platelet
•or parental corticosteroid within 1
•5. Patient receiving immunotherapy 6 months before pre-study visit
•6. Pregnant females, patients suffering from concurrent systemic disease like cardiopulmonary, diarrheal
•T.B., bronchiectasis, CHF, hepatic dysfunction, neurological disorders, and disorders or having hemoglobin less than 10 g/dl
•7. Patient having complications like CCF, Cor-pulmonale, Emphysema, Pneumonia,

发起方

DrJayanti Dutta